MIH
VRTX icon

Madison Investment Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Madison Investment Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$508K Hold
3,000
– – 0.01% 262
2019
Q2 		$550K Hold
3,000
– – 0.01% 195
2019
Q1 		$552K Hold
3,000
– – 0.01% 195
2018
Q4 		$497K Buy
+3,000
New +$520K 0.01% 202

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Madison Investment Holdings's VRTX Position: Q3 2019 in Review

Madison Investment Holdings held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2019 at 3,000 shares worth $508K. The position accounts for 0.01% of the portfolio, ranked #262.

Madison Investment Holdings first reported a position in VRTX in Q4 2018 and has held it in 4 quarters since. The position peaked at $552K in Q1 2019. 708 funds tracked by Wall St. Rank hold VRTX as of Q3 2019.

  • Madison Investment Holdings held 3,000 shares of Vertex Pharmaceuticals worth $508K as of Q3 2019.
  • Madison Investment Holdings left its Vertex Pharmaceuticals share count unchanged in Q3 2019.
  • Vertex Pharmaceuticals made up 0.01% of Madison Investment Holdings's portfolio in Q3 2019, its #262 holding.
  • Madison Investment Holdings first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 4 quarters since.
  • Madison Investment Holdings's Vertex Pharmaceuticals position peaked at $552K in Q1 2019.
  • 708 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2019.

Based on Madison Investment Holdings's 13F filing for Q3 2019, filed 13 Nov 2019.